Clinical Trial Update: Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial by the University of Birmingham aims to prevent stroke, premature death and cognitive decline in a broader community of patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University of Birmingham | Conditions: Atrial Fibrillation | Phase 4 | Status: RECRUITING